Contribution: Industrial Research Assistance Program – Contributions to Firms
Polyamyna Nanotech Inc.
$273,339.00
Clinical Research Trial of Keep Klear Transparent Microbicidal Coating Technology at Eastern Health Facility
EF 2023-24 · 2023-04-03
Résumé
Keep Klear is the first technology of its kind to be approved for clinical research trials in Canada, which is set to take place with Eastern Health. The clinical research trial is divided into 3 phases, where this innovative microbicidal technology is subjected to diversified test conditions to understand (a) its integration (b) its effectiveness (c) its impact on patient outcomes/readmissions.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
St. John's|St. John's, Newfoundland and Labrador, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
780785119
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2023-04-03 | 2023-24 | $200,000.00 |
| 1 | 2023-04-03 | 2023-24 | $273,339.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days. The total amended value is 73,339 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 91 jours. La valeur totale des modifications est de 73 339 dollars.
Agreement End Date
2025-06-30
Agreement Number
1006230
Agreement Start Date
2023-04-03
Agreement Title
Clinical Research Trial of Keep Klear Transparent Microbicidal Coating Technology at Eastern Health Facility
Agreement Title (French)
Essai de recherche clinique de la technologie de revêtement microbicide transparent Keep Klear dans un établissement de santé de l’est du pays
Agreement Type
Contribution
Agreement Value
$273,339.00
Amendment Date
2025-01-14
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Keep Klear is the first technology of its kind to be approved for clinical research trials in Canada, which is set to take place with Eastern Health. The clinical research trial is divided into 3 phases, where this innovative microbicidal technology is subjected to diversified test conditions to understand (a) its integration (b) its effectiveness (c) its impact on patient outcomes/readmissions.
Description (French)
Keep Klear est la première technologie de ce type à être approuvée pour des essais de recherche clinique au Canada, qui se dérouleront avec Eastern Health. L’essai de recherche clinique est divisé en trois phases au cours desquelles cette technologie microbicide innovante est soumise à diverses conditions d’essai pour comprendre (a) son intégration (b) son efficacité (c) son impact sur les résultats des patients/les réadmissions.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
St. John's South--Mount Pearl
Federal Riding (French)
St. John's-Sud--Mount Pearl
Federal Riding Number
10007
NAICS Code
3255
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
780785119
Recipient City
St. John's|St. John's
Recipient Country
CA
Recipient Legal Name
Polyamyna Nanotech Inc.
Recipient Operating Name
Polyamyna
Recipient Postal Code
A1E 6B5
Recipient Province or Territory
NL
Recipient Type
F
Reference Number
172-2023-2024-Q1-1006230
